Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Urolithins, ellagitannin metabolites produced by colon microbiota, inhibit Quorum Sensing in Yersinia enterocolitica: Phenotypic response and associated molecular changes

  • Giménez-Bastida, J. A.
  • Truchado, Pilar
  • Larrosa, Mar
  • Espín de Gea, Juan Carlos
  • Tomás Barberán, Francisco
  • Allende, Ana
  • García-Conesa, María Teresa
The mammalian enteropathogen Yersinia enterocolitica produces two main N-acylhomoserine lactones (AHLs) involved in Quorum Sensing (QS)-mediated infection processes, such as virulence, biofilm maturation and motility. Ellagitannin (ET)-rich fruits exhibit anti-QS activity but in vivo effects against intestinal pathogens may be associated to the ETs gut microbiota derived metabolites, urolithin-A (Uro-A) and urolithin-B (Uro-B). In this work we show that urolithins, at concentrations achievable in the intestine through the diet, reduce the levels of N-hexanoyl-l-homoserine lactone (C6-HSL) and N-(3-oxo-hexanoyl)-l-homoserine lactone (3-oxo-C6-HSL) in Y. enterocolitica and inhibit QS-associated biofilm maturation and swimming motility. These inhibitory effects were not associated to downregulation of the expression of some of the genes involved in the synthesis of AHLs (yenI and yenR) or in motility (flhDC, fliA, fleB). Our results suggest that urolithins may exert antipathogenic effects in the gut against Y. enterocolitica and highlight the need to investigate the antipathogenic in vivo properties of plant derived metabolites., This work has been supported by the following projects: Consolider Ingenio 2010-Fun-C-Food CSD2007-0063, CICYT BFU2007-60576, Fundación Seneca de la Región de Murcia (Grupo de Excelencia GERM 06, 04486) and the European Community’s Seventh Framework Programme (FP7) (244956, project BEEDOC). J.A.G.-B. and M.L. are holders of a predoctoral JAE scholarship and JAE-DOC contract, respectively, from CSIC (Spain). P.T. is holder of a predoctoral scholarship from the Fundación Seneca de la Región de Murcia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A citrus extract containing flavanones represses plasminogen activator inhibitor-1 (PAI-1) expression and regulates multiple inflammatory, tissue repair, and fibrosis genes in human colon fibroblasts

  • Giménez-Bastida, J. A.
  • Martínez-Florensa, Mario
  • Espín de Gea, Juan Carlos
  • Tomás Barberán, Francisco
  • García-Conesa, María Teresa
The consumption of flavonoid-rich Citrus extracts has been associated with multiple beneficial effects including anti-inflammatory properties, but the potential effects on the inflammatory responses in the gut have not been thoroughly investigated. We used microarrays to search for molecular changes induced in human colon fibroblasts in response to the exposure to a flavanone-rich bitter orange extract under physiologically representative conditions. Dietary nontoxic levels of the predigested extract induced moderate but significant changes in the expression of genes associated with tissue repair and inflammation. Among the top regulated genes, plasminogen activator inhibitor 1 (PAI-1) was downregulated, and the matrix metallopeptidase 12 (MMP-12) was upregulated (mRNA and protein levels). Both proteins are involved in extracellular matrix (ECM) remodeling and fibroblast migration. The extract also affected the fibroblast migration and reduced monocyte adhesion, but the response was different in unstimulated cells and in cells pretreated with TNF-alpha. Collectively, these results were indicative of a moderate activation of the colon fibroblast inflammation-related function after exposure to the extract. Further investigations are required to identify the in vivo role of this Citrus derived extract in the maintenance of the normal balance in the intestine and in the pathogenesis of inflammatory diseases., This work has been supported by Zoster S.A. (Murcia, Spain), and by the Projects 05556/PI/04 (Fundación Séneca, Murcia, Spain) and by CSD2007-00063 (Fun-C-Food; Consolider Ingenio 2010). J.A.G.B. has a JAE fellowship from the Spanish ‘Consejo Superior de Investigaciones Cinetíficas’ (CSIC), and M.M.F. had a short term contract from Zoster S.A., Peer reviewed